2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
Also known as: - Nitrosamine Impurities or nitrosamine impurities of -| Product Name | 2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one |
|---|---|
| Alternate Names | - Impurities, Impurities of - |
| CAT No. | CS-O-42672 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | Enquire |
| Mol. Wt. | 164.12 g/mol |
| Mol. For. | C6H4N4O2 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one is a chemical compound that has been extensively studied due to its potential as a therapeutic agent. It is commonly used in the pharmaceutical industry for its antimicrobial and anticancer properties.
The compound's chemical structure consists of a pyridine ring attached to a triazole ring, with a nitroso group and a carbonyl group located at positions 2 and 3 respectively. This unique structure makes it a potent inhibitor of enzymes involved in DNA synthesis, leading to its potential anticancer activity. Additionally, it has been shown to have antimicrobial activity against a range of bacteria and fungi, making it useful in the treatment of infectious diseases.
The compound's usage and chemical properties have been the subject of extensive research. It is known to undergo nitrosation reactions, leading to the formation of nitric oxide, a potent signaling molecule with various physiological functions. Additionally, its ability to inhibit enzymes involved in DNA synthesis has been extensively studied, with promising results in cancer therapy.
Overall, 2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one is a versatile compound with significant potential in the pharmaceutical industry. Its unique chemical structure and potent biological activity make it a promising therapeutic agent for the treatment of a range of diseases.
![Picture of 2-nitroso-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one](https://clearsynth.com/structure/2-nitroso--1-2-4-triazolo-4-3-a-pyridin-3-2H--one.png)
Get an Instant Quote
Related Compounds
Methyl 3-(4-methoxyphenyl)-2-methyloxirane-2-carboxylate | Nifuraldezone | Resmetirom Impurity 10 | Chlorthalidone amide impurity | N-(4-aminophenyl)-N-methylnitrous amide | L-Methyl Glyoxylate Hydrate impurity | Lenumlostat | Black cohosh | ONT 993 | N-Lauroyl-N-methyltaurine sodium salt | N-methyl-N-(5-methylthiophen-2-yl)oxalamide | N,S-Diacetylcysteamine | Nu-chek mix 17A impurity | Ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1,2-dimethyl-1H-indole-3-carboxylate | TBDMS 1α,25-dihydroxyvitamin D2 aldehyde impurity | N-methyl-N-(4-nitrosophenyl)nitrous amide | RAMIPRIL IMPURITY K DIASTEREOMER II | Hydrocortisone Impurity - 18 | Sacubitril Impurity 13 | Resmetirom Impurity 3 | Triethyl 1,3,5-benzenetricarboxylate | Methyl nonadecanoate | methyl 4-(6-(5-(2,4-difluorophenylsulfonamido)-6-methoxypyridin-3-yl)quinolin-4-yl)benzoate | N-(4-amino-3-methoxyphenyl)-N-hydroxy methanesulfonamide | N-benzyl diclofenac | Nandrolone hydrogen succinate | Methyl 4-chloro-3-(chlorosulfonyl)thiophene-2-carboxylate | ethyl 7-((5-methyl-4,4-dioxido-5,10-dihydrobenzo[c]thieno[2,3-f][1,2]thiazepin-10-yl)amino)heptanoate | Sargachromanol C | N-nitroso Indoline | Sofosbuvir impurity A | Larotrectinib (3R,2R) Sulfate | methyl 2-(dimethylamino)-2-phenylbutanoate | Sargachromanol E | Polybutylene terephthalate Impurity 1 | Decarboxymethyl Oleuropein Aglycon | methyl 3,4-dihydro-2H-1,4-benzothiazine-6-carboxylate | N-Isopropyl-5,6-dihydroxyindole | Etravirine Impurity 12 | N-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-methoxy-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine | Lumefantrine Hydroxy impurity (Mixture of Isomers) | Tandospirone Citrate Impurity I | Diiodo(p-cymene)ruthenium(II) dimer | Triiodothyroacetic acid sulfate | Tri-p-tolyl Phosphite | N-benzyl-4-methylpyridinium chloride | Safinamide ring closed impurity | N-nitroso-N-phenethyl acetamide | Bis-anhydro-Daunomycinone Carboxylic Acid | Nandrolone furylpropionate | N-(4-hydroxybutyl)-N-isopropylnitrous amide | Nu-chek mix 19A impurity | Nintedanib Impurity 63 | Bolandiol dipropionate | Larotrectinib (3S,2S) Sulfate | Valsartan Desvaleryl Methyl Ester | Ulinastatin JP Reference standard (3700 units) | Cyclotrimethylenetriamine | N-phenyl-N-(3-(trifluoromethyl)phenyl)nitrous amide | Deformyl Formoterol Citric acid adduct | N-(4H-1,2,4-triazol-4-yl)nitrous amide | Methyl 4-chloro-3-oxopentanoate | Lubiprostone Related Compound 7 | Atracurium cis-trans isomer | Samidorphan isoquinoline dioxolane | Methyl 4-bromo-2,2-dimethylbutanoate | trimethylsulfonium p-toluenesulfonate (TMSI) | Salmeterol Related Compound H | N-(4-(7-chloro-2,3-dihydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide | Methyl 4-[(2R,4S)-4-ethoxy-2-piperidinyl]benzoate |
